Home > Healthcare > Analytical Instruments > Molecular Analysis > Flow Cytometry Market

Flow Cytometry Market Share

Report ID: GMI5897
Published Date: May 2023
Report Format: PDF

Download Free Sample

Flow Cytometry Market Share

Some of the major players operating in the flow cytometry market include

Sony Biotechnology, Inc.
Becton
Dickinson and Company
Danaher Corp
Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc.
Miltenyi Biotec, Inc.
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Luminex Corporation

These participants are involved in strategic developments such as mergers and acquisitions, novel product launch, collaboration, and research and development to improve their revenue generating capabilities.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The market valuation of flow cytometry crossed USD 4.9 billion in 2022 and is estimated to exceed USD 11.2 billion by 2032 driven by technological advancements, growing biomedical research, increasing focus on personalized medicine, and a rise in cancer research and immunotherapy.

The instrument segment generated around USD 1.6 billion in 2022 and is anticipated to grow at a robust pace through 2032 owing to a wide application range, technological advancements, and increased research spending by multinational companies.

North America flow cytometry industry is expected to register gains at nearly 7.8% from 2023 to 2032 attributed to the expanding application prospect of flow cytometry in clinical settings, high disease burden rate, and increased R&D spending.

Some of the prominent firms engaged in the global market are Sony Biotechnology, Inc., Becton, Dickinson and Company, Danaher Corp, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Miltenyi Biotec, Inc., Bio-Rad Laboratories, Inc., Sysmex Corporation, and Luminex Corporation, among others.